VASCULAR-PLATELET HEMOSTASIS IN CHRONIC VIRAL LIVER DISEASES: CURRENT CONCEPTS AND CLINICAL IMPLICATIONS

Authors

  • Nuriddinova Nodira Faxriddin kizi Toshkent davlat tibbiyot universitetic

DOI:

https://doi.org/10.5281/zenodo.20525847

Keywords:

hepatotropic viruses, hepatitis, liver cirrhosis, platelets, adhesions, aggregation.

Abstract

The review of the literature provides information on changes in vascular-platelet hemostasis, platelet count, disorders of adhesion and aggregation properties, hemorrhagic complications in chronic liver disease. The results of the study of vascular-platelet hemostasis in patients with chronic liver diffuse disease were analyzed.

Downloads

Download data is not yet available.

References

1.Bulatova IA. The non-invasive accessible informative laboratory panel for detection of liver fibrosis . 2017.

2.Bilalova AR. Clinical features and hemostatic system alterations in patients with chronic hepatitis and liver cirrhosis. Moscow; 2015.

3.Kurbonova ZC. Features of hemostatic disorders in patients with chronic hepatitis and liver cirrhosis of viral etiology. Tashkent; 2019.

4.Kurkina IA, Volkova OS, Maevskaya MV, Ivashkin VT. Hemorrhagic syndrome in liver cirrhosis. Russian Journal of Gastroenterology, Hepatology and Coloproctology. 2012;22(6):14–21.

5.Pavlov CS, Shulpekova YO, Zolotarevsky VB, Kogan EA, Ivashkin VT. Modern methods of early diagnosis of liver fibrosis. Clinical Medicine. 2005;12:58–60.

6.Serov VV, Bushueva NV, Ignatova TM, Aprosina ZG. Viral and host factors in the development and progression of chronic hepatitis B and C. Russian Journal of Gastroenterology, Hepatology and Coloproctology. 2006;4:12–23.

7.Ustinova MN. Platelet aggregation in patients with chronic diffuse liver diseases and its correction by intravenous ozone therapy. Moscow; 2005.

8.Al Ghumlas AK, Abdel Gader AG, Al Faleh FZ. Haemostatic abnormalities in liver disease: could some haemostatic tests be useful as liver function tests? Blood Coagul Fibrinolysis. 2005;16(5):329–335.

9.Batirova AS, Bakanov MI, Surkov AN. The modern concepts of hemostasis system under chronic diseases of liver: the publication review. Klin Lab Diagn. 2015;60(8):40–44.

10.Bienholz A, Canbay A, Saner FH. Coagulation management in patients with liver disease. Med Klin Intensivmed Notfmed. 2016;111(3):224–234.

11.Caldwell SH, Hoffman M, Lisman T, et al. Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology. 2006;44:44.

12.Francoz C, Belghiti J, Vilgrain V, et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut. 2005;54(5):691–697.

13.Hartmann M, Cynthia S, Fuat H. Hemostasis in liver transplantation: Pathophysiology, monitoring, and treatment. World J Gastroenterol. 2016;22(4):1541–1550.

14.Hollestelle MJ, Geertzen HGM, Straatsburg IH, van Gulik TM, van Mourik JA. Factor VIII expression in liver disease. Thromb Haemost. 2004;91:267–275.

15.Hollestelle MJ, Poyck PP, Hollestelle JM, Marsman HA, Mourik JA, Gulik TM. Extrahepatic factor VIII expression in porcine fulminant hepatic failure. J Thromb Haemost. 2005;3:2274–2280.

16.Huard G, Bilodeau M. Management of anticoagulation for portal vein thrombosis in individuals with cirrhosis: a systematic review. Int J Hepatol. 2012;2012:6–7.

17.Iancu RI, Iancu D, Murărescu D, Nechifor M, Costuleanu M. Platelet functions in acute and chronic experimentally induced hepatopathia. Rev Med Chir Soc Med Nat Iasi. 2010;114(4):1101–1106.

18.Kurokawa T, Ohkohchi N. Platelets in liver disease, cancer and regeneration. World J Gastroenterol. 2017;23(18):3228–3239.

19.Northup PG, Fallon MB, Sundaram V. Hypercoagulation and thrombophilia in liver disease. J Thromb Haemost. 2008;6:2–9.

20.Nwokediuko SC, Ibegbulam O. Quantitative platelet abnormalities in patients with hepatitis B virus-related liver disease. Gastroenterol Res. 2009;2(6):344–349.

21.Sayed D, Amin NF, Galal GM. Monocyte–platelet aggregates and platelet microparticles in patients with post-hepatitic liver cirrhosis. Thromb Res. 2010;125(5):228–233.

22.Tripodi A. Hemostasis abnormalities in cirrhosis. Curr Opin Hematol. 2015;22:406–411.

23.Zaldivar MM, Pauels K, Von Hundelshausen P, Berres ML, Schmitz P. XC chemokine ligand 4 (CXCL4) is a platelet-derived mediator of experimental liver fibrosis. Hepatology. 2010;51(4):1345–1353.

Downloads

Published

2026-06-03

Issue

Vol. 5 No. 6 (2026): Journal of Multidisciplinary Sciences and Innovations

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

How to Cite

VASCULAR-PLATELET HEMOSTASIS IN CHRONIC VIRAL LIVER DISEASES: CURRENT CONCEPTS AND CLINICAL IMPLICATIONS. (2026). Journal of Multidisciplinary Sciences and Innovations, 5(6), 30-33. https://doi.org/10.5281/zenodo.20525847

Similar Articles

1-10 of 73

You may also start an advanced similarity search for this article.